While an earlier cs78 targeting peptide exhibited toxicity observed only in nonhuman primates, it is associated with the peptide sequence, not GRP78 (113), and new peptide ligand has been identified that binds GRP78 in a screening using a PDX model of prostate cancer (112). The gene discussed is HSPA5; the disease is prostate carcinoma.